Histone deacetylase inhibitors in multiple myeloma
Novel drugs such as bortezomib and high-dose chemotherapy combined with stem cell transplantation improved the outcome of multiple myeloma patients in the past decade. However, multiple myeloma often remains incurable due to the development of drug resistance governed by the bone marrow microenviron...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
PAGEPress Publications
2009
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222248/ |